40
Crosslink Therapeutics closes $5.5M raise in Boston
Company raise · Closed · Offering $5.5M · Sold $5.5M · BOSTON, MA · filed 2026-10-20
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| Ronald D. Seidel, III | Executive Officer, Director |
| Cameron D. Gallagher | Director |
| Lou D. Tartaglia | Director |
| Rodolfo D. Chaparro | Director |
| Andrew D. King | Executive Officer |
Signed by Ronald D. Seidel III, Chief Executive Officer.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.